European Federation for Pharmaceutical Sciences

1
European Federation for Pharmaceutical Sciences

• Advances Pharmaceutical Sciences
• Represents Pharmaceutical Scientists

EAFP Meeting, Lille, France June 12-14, 2008
Established in 1991
2
The Mission of EUFEPS

• The mission of the European Federation for
• Pharmaceutical Sciences (EUFEPS) is to serve and
  advance excellence in the pharmaceutical
• sciences and innovative drug research in Europe,
• including in training and education, and to
• represent the interests of scientists engaged in
• drug research and development, drug regulation,
• drug utilisation, and drug policy making.

Strategic Plan 2006-2010
3
Why invest in EUFEPS?

• To underpin the only pan-European body for
  pharmaceutical/drug scientists (whatever origin,
  domain or discipline)
• To proactively support systems approaches in
  European collaboration, co-operation and
  co-ordination for better drug research and
  development
• To further strengthen the European voice and
  platform for needs and progress communication
  along with beneficial networking

4
EUFEPS Membership

• Member Societies
• 24 in 24 European countries (including Israel
  and Turkey)
• Member Institutions
• 12 European universities/research institutes
• Member Individuals
• Around 500, including non-European

5
EUFEPS Platforms of Operation

• Membership
• Networks
• Senate
• Research and Policy Collaboration
• The PharmSciFair
• Meetings and Events
• Education and Training
• Communication
• Finance and Funding
• Presidents Conference
• Council and Open Forum
• Executive Committee
• Chair Daan JA Crommelin, EUFEPS President
• Central Office in Stockholm SE

6
Structural Approaches Tasks
Will follow
Senate Senators 50-100
Leadership Forum Presidents Currently 10
Meetings Events SC 2nd 2009 with Partners
EUFEPS Committee/s
As of May 2007
7
European Federation for Pharmaceutical Sciences

• a systems approach,
• obviously

secretariat_at_eufeps.org
Established in 1991
8
Pharmaceutical Sciencesfor Innovative Medicines
Discovery
From EUFEPS Institutional Peer Review Workshop,
January 14-15, 2008, Leiden NL (HH Linden)
9
Pharmaceutical Sciencesfor Innovative Medicines
Discovery
Development
From EUFEPS Institutional Peer Review Workshop,
January 14-15, 2008, Leiden NL (HH Linden)
10
Pharmaceutical Sciencesfor Innovative Medicines
Discovery
Development
Distribution (Pharmacy)
From EUFEPS Institutional Peer Review Workshop,
January 14-15, 2008, Leiden NL (HH Linden)
11
Pharmaceutical Sciencesfor Innovative Medicines
Discovery
Development
Manufacturing
Distribution (Pharmacy)
3
2
1
4
From EUFEPS Institutional Peer Review Workshop,
January 14-15, 2008, Leiden NL (HH Linden)
12
Pharmaceutical Sciencesfor Innovative Medicines
Prescribing Support
Discovery
Development
Manufacturing
5
Distribution (Pharmacy)
3
2
1
4
From EUFEPS Institutional Peer Review Workshop,
January 14-15, 2008, Leiden NL (HH Linden)
13
Pharmaceutical Sciencesfor Innovative Medicines
Prescribing Support
Discovery
Development
Manufacturing
Medication Support
5
Distribution (Pharmacy)
3
6
2
1
4
From EUFEPS Institutional Peer Review Workshop,
January 14-15, 2008, Leiden NL (HH Linden)
14
Pharmaceutical Sciencesfor Innovative Medicines
Prescribing Support
Discovery
Development
Manufacturing
Medication Support
5
Distribution (Pharmacy)
3
6
2
1
4
Competencies Foundation Education and Training
7
From EUFEPS Institutional Peer Review Workshop,
January 14-15, 2008, Leiden NL (HH Linden)
15
Pharmaceutical Sciencesfor Innovative Medicines
Operational Window Legaland Regulatory Framwork
8
Prescribing Support
Discovery
Development
Manufacturing
Medication Support
5
Distribution (Pharmacy)
3
6
2
1
4
Competencies Foundation Education and Training
7
From EUFEPS Institutional Peer Review Workshop,
January 14-15, 2008, Leiden NL (HH Linden)
16
Pharmaceutical Sciencesfor Innovative Medicines
Operational Window Legaland Regulatory Framwork
8
Prescribing Support
Discovery
Development
Manufacturing
Medication Support
5
Distribution (Pharmacy)
3
6
2
1
4
Competencies Foundation Education and Training
7
Qualitatively different phases and roles in
discovery, development and use of medicines
From EUFEPS Institutional Peer Review Workshop,
January 14-15, 2008, Leiden NL (HH Linden)
17
Important needs

• Industrial needs but not only
• Transnational/regional standardisation
• Quality high all through
• Priorities different communities and levels

18
Education and Training Levels

• Bachelor 3 years
• Master 2 years
• Additional.

• PostGraduate Master 1 (?) year
• PhD 4 (?) years

19
EUFEPS Meetings Events
20
European Federation for Pharmaceutical Sciences

• www.eufeps.org
• secretariat_at_eufeps.org

Established in 1991